Ganciclovir and foscarnet dual-therapy for cytomegalovirus encephalitis: a case report and review of the literature
Cytomegalovirus (CMV) is a ubiquitous herpesvirus which establishes lifelong latency
following primary infection. It is then capable of reactivating in the face of …
following primary infection. It is then capable of reactivating in the face of …
Ganciclovir and foscarnet dual-therapy for cytomegalovirus encephalitis: A case report and review of the literature
A Baghban, M Malinis - Journal of the neurological …, 2018 - pubmed.ncbi.nlm.nih.gov
Cytomegalovirus (CMV) is a ubiquitous herpesvirus which establishes lifelong latency
following primary infection. It is then capable of reactivating in the face of …
following primary infection. It is then capable of reactivating in the face of …
Ganciclovir and foscarnet dual-therapy for cytomegalovirus encephalitis: A case report and review of the literature
A Baghban, M Malinis - Journal of the Neurological Sciences, 2018 - jns-journal.com
Cytomegalovirus (CMV) is a ubiquitous herpesvirus which establishes lifelong latency
following primary infection. It is then capable of reactivating in the face of …
following primary infection. It is then capable of reactivating in the face of …
Ganciclovir and foscarnet dual-therapy for cytomegalovirus encephalitis: A case report and review of the literature.
A Baghban, M Malinis - Journal of the Neurological Sciences, 2018 - europepmc.org
Cytomegalovirus (CMV) is a ubiquitous herpesvirus which establishes lifelong latency
following primary infection. It is then capable of reactivating in the face of …
following primary infection. It is then capable of reactivating in the face of …